TREATMENT WITH ANTI-ALPHA2 INTEGRIN ANTIBODIES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130084285A1
SERIAL NO

13593285

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a formulation of an anti-α2 integrin antibody for administration to a patient, which is suitable for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLENMARK PHARMACEUTICALS S A2300 LA CHAUX-DE-FONDS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mottl, Harald La Chaux-de-Fonds, CH 5 38

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation